Our previous studies demonstrated that among phenothiazines several derivatives could be found showing strong antiproliferative actions and the property of inhibiting inducible tumor necrosis factor alpha (TNF α) production in human blood cultures. The aim of this investigation was to determine potential antimicrobial actions of forty four new phenothiazine derivatives with the quinobenzothiazine structure. The compounds showed differential antibacterial and antifungal activities against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans depending on the compound structures, concentrations and bacterial strains. More specifically, 6-(1-methyl-2-piperidylethyl) quinobenzothiazine displayed strongest actions against S. aureus and E. coli whereas 6-methanesulfonylaminobutyl-9-methylthioquinobenzothiazine exhibited the most universal antimicrobial properties. The correlation between antimicrobial activity and the chemical structure of quinobenzothiazines was discussed.
Introduction
Phenothiazines exhibit wide spectrum of significant biological activities and belong to recognized antipsychotic, antihistaminic, antitussive and antiemetic drugs (Gupta and Kumar, 1988) . The introduction of new substituents into the phenothiazine skeleton as well as the modification of the tricyclic ring system alter biological activities. Both classical and new modified phenothiazines were recently reported to have promising: anticancer, antibacterial, antiviral and anti-inflammatory activities (Gaye-Seye et al., 2006; Motohashi et al., 2006; Dasgupta et al., 2008; Aaron et al., 2009; Pluta et al., 2011; Jaszczyszyn et al., 2012) . They are able to modify multidrug resistance and may be potentially used in the treatment of Alzheimer's, Creutzfeldt-Jakob's and AIDS diseases (Amaral and Kristiansen, 2001; Pluta et al., 2011; Jaszczyszyn et al., 2012) . The antimicrobial activity was first observed for the phenothiazine compound, chlorpromazine, against Bacillus anthra cis in 1976 (Molnar et al., 1976) . During over three decades prominent classical phenothiazines such as: chlorpromazine, promethazine, trifluoperazine, fluphenazine, levomepromazine, diethazine, trimeprazine and thioridazine were broadly examined for their antimicrobial activities. These results were collected in an excellent chapter written by Dasgupta et al. (2008) . Antimicrobial potencies were reported for all examined phenothiazines. They were active both in vitro and in vivo and some of them could act in synergy with antibiotics against many genera, including enterobacteria, staphylococci and mycobacteria. Newly synthesized phenothiazines, possessing tri-, tetra-and pentacyclic ring system with various substituents (acyclic or cyclic) at the thiazine and/or carbon atoms, exhibited antibacterial and antifungal activities, in some cases equivalent or even more active than the reference drugs such as: ciprofloxacin, streptomycin, gentamycin, ampicillin, fluconazole and other (Singh et al., 2003; Raval and Desai, 2005; Srivastava and Kohli, 2007; Swarnkar et al., 2007; Bansode et al., 2009a and 2009b; Dixit et al., 2009; Salvi et al., 2009) .
We modified the phenothiazine structure by introduction of the pyridine and quinoline rings, instead of the benzene ones, to form tricyclic, tetracyclic and pentacyclic azaphenothiazines (Pluta et al., 2000; Morak and Pluta, 2007; Nowak et al., 2007; Jeleń and Pluta, 2008; (Pluta et al., 2010; Jeleń et al., 2013) . They also inhibited lipopolysaccharide-induced production of tumor necrosis factor alpha (TNF α) (Zimecki et al., 2009; Jeleń et al., 2013) . Another azaphenothiazine, 10H-dipyridothiazine, was found to be an universal, low-toxic immunosuppressant, inhibiting both humoral and cellular immune response (Zimecki et al., 2009) . Recently obtained, angularly fused quinobenzothiazinones and quinobenzothiazinium salts, exhibited antioxidant, antiproliferative and antimicrobial activities (Kumar et al., 2010; Zięba et al., 2010; Table I ).
Experimental Materials and Methods
In the studies the following compound concentrations were used: 500 μg/ml, 250 μg/ml and 125 μg/ml. The compounds were initially dissolved in DMSO (dimethyl sulfoxide) at 1 mg/ml concentration, subsequent dilutions were prepared in water. The experiments were conducted on strains derived from the Polish Collection of Microorganisms (PCM) The media were from BTL, Łódź, Poland. Preliminary studies were aimed at selection of the most active compounds. Precultures of tested strains of E. coli, P. aeruginosa and S. aureus in broth were incubated at 37°C, and C. albicans in Sabouraud's broth at 28°C. After an overnight incubation the bacterial cultures were diluted 10 × with broth and the yeast cultures with Sabouraud's broth. The suspensions (100 μl) of the microorganisms were plated onto nutrient agar or Sabouraud's agar. The plates were dried and 20 μl of the studied compound solutions at concentrations of: 500 µg/ml, 250 µg/ml and 125 µg/ml were applied. Control plates were treated with appropriate dilutions of DMSO. The plates were incubated for 24 h and the growth of bacterial or Candida colonies was evaluated. When the sample solution contained antimicrobial activity, a clear zone of growth inhibition on the agar was observed. Each test was performed in triplicate. The results are shown in Table II. For further tests the most active compounds were chosen and the method of dilutions was applied. Precultures of E. coli, P. aeruginosa and S. aureus strains in the culture broth were incubated for 18-20 h at 37°C.
Into wells of 24-well culture plates 1 ml of the bacterial culture liquid was applied, followed by addition of the tested compounds at appropriate concentrations. After 24 h incubation 100 μl of the bacteria culture was aspirated, diluted with 0.9% NaCl and seeded (100 μl) onto agar plates. After an overnight incubation at 37°C the numbers of colonies (colony forming units) were enumerated. The control cultures included: 1) no tested compounds, bacteria seeded at time "0 h", 2) no tested compounds, bacteria seeded at time "24 h",
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- 3) containing appropriate DMSO dilutions (50, 25 and 12.5%) incubated for 24 h, 4) containing chlorpromazine chloride at 500, 250 and 125 μg/ml (a reference drug). The results are presented in Tables III-V .
Results
The compounds investigated in this report represented three types of substituted azaphenothiazines: 8-10-substituted 6H-quinobenzothiazines (1-12), 6-substituted quinobenzothiazines (13-15, 18, 21, 24,  27, 30, 33, 36, 39, 42 ) and 6,9-disubstituted quinobenzothiazines (16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31,  32, 34, 35, 37, 38, 40, 41, 43, 44) (Fig. 1. and Table I ). The compounds were screened for antibacterial activity against Gram-positive (S. aureus) and Gram-negative (E. coli, P. aeruginosa) strains as well as antifungal activity against C. albicans. Table II contains results for only the most active (nine) antimicrobial compounds at concentrations of 500, 250 and 125 μg/ml. None of the 6H-quinobenzothiazines (1-12) exhibited antimicrobial activity (data not shown). S. aureus was the most sensitive strain and C. albicans the most resistant one for quinobenzothiazines (Table II) . The antibacterial activities of selected compounds (14, 31, 38) against E. coli, P. aeruginosa and S. aureus are presented in Tables III-V, respectively. The growth of E. coli (Table III) was markedly inhibited by compound 14 at 250 and 500 μg/ml concentrations, whereas the activities of compounds 31 and 38 were rather week. In turn, the growth of P. aeru ginosa (Table IV) was more clearly inhibited by 38 (250 and 500 μg/ml) in contrast to inactive 18 and 19 which were initially found antibacterial for S. aureus. Lastly, compound 14 was found active with regard to S. aureus at 250 and 500 μg/ml (Table V) . In addition, 31 and 38 showed some activity at lower concentration (125 μg/ml).
Discussion
New quinobenzothiazines (1-44), shown in Fig. 1 . and Table I , were recently synthesized in reactions of dichlorodiquinolinyl disulfide or diquinodithiin with substituted anilines and their hydrochlorides, followed by N-alkylation Jeleń et al., 2013) . They contain various substituents at the thiazine nitrogen atom: the hydrogen atom and pharmacophoric groups such as dialkylaminoalkyl diethylaminopropyl and 1-methyl-2-piperidinylethyl), acetylaminoalkyl, ethoxycarbonylaminoalkyl, chloroethylureidoalkyl, methanesulfonylaminoalkyl and p-toluenesulfonylaminoalkyl ones (where alkyl = propyl and butyl) and a simple substituent in the benzene ring: H, Cl, Br, CF 3 and SCH 3 . These quinobenzothiazines were found to be antiproliferative, generally low cytotoxic and inhibitory with regard to TNF α production. The selected compounds exhibited anticancer activities against leukemia L-1210 cells, colon cancer SV-948 cells and epidermal carcinoma A-341 cells with a potency similar to cisplatin (Jeleń et al., 2013) .
The results of this investigation showed (Table II ) that active compounds possess nitrogen group substituents at the thiazine nitrogen atom: chloroethylureidoalkyl, acetylaminoalkyl, ethoxycarbonylaminoalkyl and methanesulfonylaminoalkyl ones. The two former substituents were also present in the most potent antiproliferative and anticancer 6-substituted quinobenzothiazines (Jeleń et al., 2013) . The additional substituent (Cl, SCH 3 ) in position 9 did not significantly influence the tested activity. As the most active compounds show similar lipophilicity to 8-10-substituted 6H-quinobenzothiazines (1-12) (logP = 4.01-5.41) (Jeleń et al., 2014) , the lipophilic character does not play an important role in antimicrobial activity.
In summary, although compound 38 (6-methanesulfonylaminobutyl-9-methylthioquinobenzothiazine) turned out to be the most universal antimicrobial quinobenzothiazine as assessed by analysis of Table II , compound 14 (6-(1-methyl-2-piperidylethyl)quinobenzothiazine) showed stronger actions against S. aureus and E. coli. Although the studied quinobenzothiazines were less active than the reference drug chlorpromazine, compounds 38 and 14 were non-toxic with regard to human peripheral blood mononuclear cells as demonstrated elsewhere (Jeleń et al., 2013) .
Conclusion. Structure-activity relationship revealed that linearly fused quinobenzothiazines exhibit modest antimicrobial activity, weaker than angularly fused quinobenzothiazines. The nitrogen substituent at the thiazine nitrogen atom is necessary for their antibacterial activity. Although the antimicrobial activities of the studied compounds are considerably weaker than chlorpromazine, they surpass chlorpromazine by much lower cell toxicity. Although the compounds were primarily designed as potential anti-inflammatory drugs, the accompanying antibacterial properties increase attractiveness of the compounds as potential therapeutics. 
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